Unstable Angina

more rapid in onset and may be preferred. Either a low molecular weight heparin (LMWH), unfractionated heparin, or bivalirudin is given routinely to patients with unstable angina unless contraindicated (eg, by active bleeding). Unfractionated heparin is more complicated to use because it requires frequent (every 6 hours) dosing adjustments to achieve target activated partial thromboplastin time (aPTT). The LMWHs have better bioavailability, are given by simple weight-based dose without monitoring aPTT and dose titration, and have lower risk of heparin- induced thrombocytopenia. Bivalirudin is recommended for patients with a known or suspected history of heparin-induced thrombocytopenia. Consider a glycoprotein IIb/IIIa inhibitor during PCI for patients with high-risk lesions (eg, high thrombus burden, no reflow). Abciximab, tirofiban, and eptifibatide appear to have equivalent efficacy, and the choice of agent should depend on other factors (eg, cost, availability, familiarityâ€”3). Chest pain can be treated with nitroglycerin or sometimes morphine. Nitroglycerin is preferable to morphine, which should be used judiciously (eg, if a patient has a contraindication to nitroglycerin or is in pain despite maximal nitroglycerin therapy). Nitroglycerin is initially given sublingually, followed by continuous IV drip if needed. Morphine, given 2 to 4 mg IV, repeated every 15 minutes as needed, is
